By Drug Target Review2024-03-25T12:00:16
Whole genome sequencing identified 17 significant variants associated with AD risk in five genomic regions.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-26T13:58:00Z
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud